Published in J Virol on August 01, 1999
An innate antiviral pathway acting before interferons at epithelial surfaces. Nat Immunol (2015) 2.09
Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms. J Virol (2005) 1.45
Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol (2010) 1.45
Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J Virol (2003) 1.37
Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol (2007) 1.26
Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells. J Virol (2001) 1.21
Herpes simplex virus and the chemokines that mediate the inflammation. Curr Top Microbiol Immunol (2006) 1.20
CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration. J Virol (2009) 1.18
Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords. J Virol (2008) 1.16
Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. J Virol (2006) 1.16
Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection. J Virol (2001) 1.07
NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob Agents Chemother (2003) 1.07
Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation. J Virol (2005) 1.06
Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines. J Virol (2001) 1.03
Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection. J Virol (2010) 0.94
Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms. J Reprod Immunol (2007) 0.91
Neutrophils recruited by IL-22 in peripheral tissues function as TRAIL-dependent antiviral effectors against MCMV. Cell Host Microbe (2014) 0.90
Early resolution of herpes simplex virus type 2 infection of the murine genital tract involves stimulation of genital parenchymal cells by gamma interferon. J Virol (2006) 0.86
The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection. Immunology (2006) 0.85
RNA-dependent protein kinase is required for alpha-1 interferon transgene-induced resistance to genital herpes simplex virus type 2. J Virol (2005) 0.85
Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection. Open Immunol J (2008) 0.85
HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway. PLoS One (2013) 0.81
Comparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites. J Virol (2012) 0.81
Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice. J Virol (2008) 0.81
Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus. Immunology (2006) 0.80
Prophylactic and therapeutic modulation of innate and adaptive immunity against mucosal infection of herpes simplex virus. Immune Netw (2014) 0.80
Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLoS One (2014) 0.80
Protective effect of avian myelomonocytic growth factor in infection with Marek's disease virus. J Virol (2002) 0.77
Involvement of intracellular free Ca2+ in enhanced release of herpes simplex virus by hydrogen peroxide. Virol J (2006) 0.77
Cervico-vaginal immunoglobulin G levels increase post-ovulation independently of neutrophils. PLoS One (2014) 0.76
Distinct Upstream Role of Type I IFN Signaling in Hematopoietic Stem Cell-Derived and Epithelial Resident Cells for Concerted Recruitment of Ly-6Chi Monocytes and NK Cells via CCL2-CCL3 Cascade. PLoS Pathog (2015) 0.76
Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists. PLoS One (2016) 0.75
Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis (1992) 10.85
Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest (1985) 8.63
Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol (1985) 7.20
Latent herpes simplex virus in spinal ganglia of mice. Science (1971) 7.04
Stimulation of neutrophils by tumor necrosis factor. J Immunol (1986) 5.72
Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol (1991) 5.02
The production of cytokines by polymorphonuclear neutrophils. Immunol Today (1995) 4.27
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89
Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest (1986) 3.78
Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature (1985) 3.73
Human herpesviruses: a consideration of the latent state. Microbiol Rev (1989) 3.15
Determining the stage of the estrous cycle in the mouse by the appearance of the vagina. Biol Reprod (1973) 3.14
Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00
A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest (1994) 3.00
Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology (1997) 2.37
T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J Immunol (1998) 2.31
Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J Virol (1984) 2.29
Immune interferon enhances functional properties of human granulocytes: role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor. J Immunol (1987) 2.24
Critical roles of neutrophils in host defense against experimental systemic infections of mice by Listeria monocytogenes, Salmonella typhimurium, and Yersinia enterocolitica. Infect Immun (1997) 2.15
Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol (1996) 2.14
On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol (1997) 2.14
Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology (1995) 1.86
Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J Leukoc Biol (1987) 1.81
Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol (1995) 1.75
Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells. Clin Exp Immunol (1977) 1.73
Neutrophil activation by recombinant cytokines. Rev Infect Dis (1989) 1.63
Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection. Infect Immun (1996) 1.53
Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J Virol (1998) 1.47
The crucial role of polymorphonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice. Proc Natl Acad Sci U S A (1998) 1.40
Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2. J Infect Dis (1977) 1.32
IFN-gamma is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils. J Immunol (1998) 1.23
Neutrophil-mediated antibody-dependent killing of herpes-simplex-virus-infected cells. Blood (1979) 1.14
Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine(s). J Immunol (1998) 1.12
Genital reinfection after recovery from initial genital infection with herpes simplex virus type 2 in guinea pigs. J Infect Dis (1986) 0.96
Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. J Virol (1985) 0.96
Different effects of IFN gamma and IFN alpha/beta on "immediate early" gene expression of HSV-1. Virology (1990) 0.96
The histopathologic evolution of recurrent herpes simplex labialis. J Am Acad Dermatol (1981) 0.95
Phagocytosis of herpes simplex virus by human granulocytes and monocytes. Arch Virol (1989) 0.90
Characterization of neutrophils and T lymphocytes associated with the murine vaginal epithelium. Reg Immunol (1994) 0.87
Experimental model for activation of genital herpes simplex virus. J Infect Dis (1985) 0.83
HSV-2 replication sites, monocyte and lymphocytic cell infection and virion phagocytosis by neutrophils, in vesicular lesions on penile skin. Electronoptical studies of a biopsy. J Cutan Pathol (1987) 0.80